Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
1.370
-0.130 (-8.67%)
Oct 16, 2026, 4:00 PM EDT - Market closed
Century Therapeutics Revenue
In the year 2025, Century Therapeutics had annual revenue of $109.16M with 1,556.76% growth. That makes Century Therapeutics the 21,961st largest company in the world by revenue and 3,234th in the United States.
Revenue (ttm)
$109.16M
Revenue Growth
+1,556.76%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
78
Market Cap
248.07M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 109.16M | 102.58M | 1,556.76% |
| Dec 31, 2024 | 6.59M | 4.35M | 194.81% |
| Dec 31, 2023 | 2.24M | -2.96M | -57.01% |
| Dec 31, 2022 | 5.20M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Vanda Pharmaceuticals | 215.72M |
| Bicycle Therapeutics | 61.21M |
| Abeona Therapeutics | 25.52M |
| AC Immune | 21.67M |
| X4 Pharmaceuticals | 15.85M |
| Lineage Cell Therapeutics | 13.08M |
| EyePoint | 2.79M |
| Palisade Bio | 500.00K |
IPSC News
- 4 days ago - Century Therapeutics to Attend 2026 Jefferies Global Healthcare Conference in London - GlobeNewsWire
- 16 days ago - Century Therapeutics announces presentation of nonclinical data for CNTY-813 - TheFly
- 16 days ago - Century Therapeutics announces presentation of nonclinical data for CNTY-813 - TheFly
- 16 days ago - Century Therapeutics' CNTY-813 Demonstrates Continued Advancement Toward the Clinic Via Nonclinical Data Presented at EASD 2026 - GlobeNewsWire
- 5 weeks ago - Century Therapeutics Appoints Joseph Truitt to Board of Directors - GlobeNewsWire
- 2 months ago - Century Therapeutics reports Q2 EPS (17c), consensus (12c) - TheFly
- 2 months ago - Century Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates - GlobeNewsWire
- 2 months ago - Century Therapeutics Quarterly report: Q2 2026 - Filings